📰 Daniel Weghuber News
Daniel Weghuber News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Weghuber. Real-time updates on events, politics, business and more.
May 19, 2023
Austria: Semaglutide use may significantly reduce the liver enzymes indicative of liver damage, a new substudy of the STEP TEENS trial has revealed.The findings, presented at the European Congress on...
May 17, 2023
Overall, nearly half dropped below threshold for obesity
December 30, 2022
Given the positive results from the trial, the US FDA approved semaglutide for obese/overweight teenagers.
November 6, 2022
Quotable quotes heard by <em>MedPage Today</em>'s reporters
November 3, 2022
(Bloomberg) -- Novo Nordisk A/S’s weekly shot that reduces obesity in adults returned promising results in teens, according to a study that adds to a growing…
November 3, 2022
Austria: A recent study has found that once-weekly treatment with a 2.4-mg dose of semaglutide combined with lifestyle intervention led to a more significant reduction in BMI than lifestyle...
November 3, 2022
The so-called gamechanger obesity injection, semaglutide, is trialed in teenagers with obesity and comes up trumps.
October 21, 2022
Pediatric obesity is a serious disease and its prevalence has increased during the COVID-19 pandemic. Many factors can contribute to excess weight gain in youth including genetics/biology, the obesogenic environment, stress and sleep routines.